News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Trinity’s 22.9% return over the past six months has outpaced the S&P 500 by 11.9%, and its stock price has climbed to $32.41 per share. This performance may have investors wondering how to approach the situation.
Over the past six months, Hartford’s shares (currently trading at $127.05) have posted a disappointing 6.2% loss, well below the S&P 500’s 10.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
Over the last six months, Clorox’s shares have sunk to $90.24, producing a disappointing 15.2% loss - a stark contrast to the S&P 500’s 10.9% gain. This might have investors contemplating their next move.
Crown Holdings has been treading water for the past six months, recording a small loss of 2.3% while holding steady at $95.12. The stock also fell short of the S&P 500’s 10.9% gain during that period.
The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. exposure, while the other adds global reach in a sector shaped by drug pricing, patent cycles, regulation, and medical innovation.
SpaceX just filed its S-1 ahead of what could be the largest IPO in history.
The Hanover Insurance Group has been treading water for the past six months, holding steady at $186.29. The stock also fell short of the S&P 500’s 10.9% gain during that period.
Over the past six months, B&G Foods’s shares (currently trading at $4.09) have posted a disappointing 12.2% loss, well below the S&P 500’s 10.9% gain. This might have investors contemplating their next move.
Flagstar Financial has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.3% to $14.06 per share while the index has gained 10.9%.
Over the past six months, Guardant Health has been a great trade, beating the S&P 500 by 11.7%. Its stock price has climbed to $129.08, representing a healthy 22.7% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Money-losing tech stocks outpaced major indexes as strategists warn about rising yields and speculation.
Over the past six months, Estée Lauder’s stock price fell to $89.27. Shareholders have lost 5.7% of their capital, which is disappointing considering the S&P 500 has climbed by 10.9%. This may have investors wondering how to approach the situation.
General Dynamics has been treading water for the past six months, recording a small return of 4.5% while holding steady at $347.44. The stock also fell short of the S&P 500’s 10.9% gain during that period.
David Ricks was addressing the pharmaceutical titan's latest hot product.
Nvidia announced its next-gen AI platform and surged 5%. But Apple, Amazon, Tesla, and Meta didn't get invited to the party, and oil prices are up. As a result, the top market indexes barely moved today.
The consumer discretionary sector is split. While McKinsey reports that up to 50% of consumers are cutting big-ticket retail like apparel, the broader slowdown is partially masked by a classic substitution effect: consumers priced out of major luxuries are redirecting cash into affordable, small premium indulgences. [1.
Greg Abel's first big Berkshire deal looks familiar on purpose: cash, housing, and an understandable business. But there's a twist.
Financial institutions play a critical role, offering everything from consumer banking to wealth management and specialized financial solutions. But worries about economic uncertainty and potential market volatility have kept sentiment in check, and over the past six months, the industry’s return was flat while the S&P 500 climbed by 10.9%.
People Inc. offers $48.30 per share for the MGM stake it does not already own.
Iran deal hopes, AI-fueled tech gains and Dell's upbeat outlook lifted stocks to record highs, while inflation fears and space-stock volatility persisted.
From commerce to culture, software is digitizing every aspect of our lives. In the past, the undeniable tailwinds fueling SaaS companies led to lofty valuation multiples that made it easier to raise capital. But this was a double-edged sword as the high prices exposed them to big drawdowns, and unfortunately, the industry has tumbled by 3.2% over the last six months. This drawdown is a noticeable divergence from the S&P 500’s 10.9% return.
By Chibuike Oguh NEW YORK, June 1 (Reuters) - Global stocks clung to record highs on Monday as strong corporate results, fueled in part by artificial intelligence optimism, outweighed investor
STAAR Surgical supplies implantable lenses for vision correction, serving ophthalmic surgeons and clinics globally with proprietary tech.
Voss Capital, LLC, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. Voss Capital’s funds, Voss Value Fund, LP, and the Voss Value Offshore Fund, Ltd returned -11.4% and -11.5%, respectively, to investors net of fees and expenses, in the first quarter compared to a […]
Chime looks to be a key player in the Trump Accounts game.